The human
cyclophilin hCyp-18, an abundant
peptidyl-prolyl cis-trans isomerase (
PPIase) implicated in protein folding, controls the
infection of CD4(+) T-cells by HIV-1, the pathologic agent of
AIDS. Therefore,
hCyp-18 is an interesting target for the development of novel anti-HIV-1
therapeutics. We focused on the design of transition-state analogue inhibitors of the
PPIase activity of
cyclophilin. Most experimental results reported in the literature suggest that
hCyp-18 catalyzes the pyramidalization of the
nitrogen of
pyrrolidine via an H-bond network which results in the deconjugation of the amino acyl-prolyl
peptide bond. We proposed the Glypsi(PO(2)R(1)-N)Pro motif (R = alkyl or H) as a selective transition-state analogue inhibitor of
cyclophilin. This motif was inserted in Suc-
Ala-Ala-Pro-Phe-pNA, a
peptide substrate of
hCyp-18. The pseudopeptide Suc-Ala-Glypsi(PO(2)Et-N)Pro-Phe-pNA 1b bound to
hCyp-18 (K(d) = 20 +/- 5 microM) and was able to selectively inhibit its
PPIase activity (IC(50) = 15 +/- 1 microM) but not hFKBP-12, another important
PPIase. Deprotection of the phosphonamidate moiety resulted in a complete lack of inhibition. We previously demonstrated that reduction of the Phe-pNA moiety caused a quantitative reduction of the affinity; however, Suc-Ala-Glypsi(PO(2)Et-N)Pro-Phepsi(CH(2)-NH)pNA 7b still bound and inhibited
hCyp-18, suggesting that the Glypsi(PO(2)Et-N)Pro motif plays the major role in the binding to
cyclophilin. Consequently, we propose compound 1b as being a novel transition-state mimic inhibitor of
hCyp-18.